CN Patent

CN1668283A — 具有提高的溶出度的药物组合物

Assigned to Transform Pharmaceuticals Inc · Expires 2005-09-14 · 21y expired

What this patent protects

本发明涉及筛选含药物化合物和赋形剂的混合物，以鉴定药物化合物/赋形剂组合延缓固态核化的性质的方法。本发明还涉及通过使在胃液条件下具有低溶解度的药物与重结晶/沉淀延缓剂以及任选的增强剂联合，提高药物的溶解度、溶出度和生物利用度。

USPTO Abstract

本发明涉及筛选含药物化合物和赋形剂的混合物，以鉴定药物化合物/赋形剂组合延缓固态核化的性质的方法。本发明还涉及通过使在胃液条件下具有低溶解度的药物与重结晶/沉淀延缓剂以及任选的增强剂联合，提高药物的溶解度、溶出度和生物利用度。

Drugs covered by this patent

Patent Metadata

Patent number
CN1668283A
Jurisdiction
CN
Classification
—
Expires
2005-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Transform Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.